Role for telomerase in pulmonary hypertension

• Published in: Circulation (New York, N.Y.) N.Y.), 2015-02, Vol.131 (8), p.742-755
• Main Authors: Mouraret, Nathalie, Houssaïni, Amal, Abid, Shariq, Quarck, Rozenn, Marcos, Elisabeth, Parpaleix, Aurelien, Gary-Bobo, Guillaume, Dubois-Randé, Jean-Luc, Derumeaux, Geneviève, Boczkowski, Jorge, Delcroix, Marion, Blasco, Maria A, Lipskaia, Larissa, Amsellem, Valérie, Adnot, Serge
• Format: Article
• Language: English
• Subjects: Adult; Animals; Cell Proliferation - physiology; Cells, Cultured; Disease Models, Animal; Female; Humans; Hypertension, Pulmonary - etiology; Hypertension, Pulmonary - pathology; Hypertension, Pulmonary - physiopathology; Hypoxia - complications; Indoles - pharmacology; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; Middle Aged; Muscle, Smooth, Vascular - drug effects; Muscle, Smooth, Vascular - pathology; Muscle, Smooth, Vascular - physiopathology; Niacinamide - analogs & derivatives; Niacinamide - pharmacology; Oligonucleotides; Pulmonary Artery - drug effects; Pulmonary Artery - pathology; Pulmonary Artery - physiopathology; Serotonin Plasma Membrane Transport Proteins - genetics; Serotonin Plasma Membrane Transport Proteins - physiology; Telomerase - deficiency; Telomerase - genetics; Telomerase - physiology
• ISSN: 0009-7322; 1524-4539
• DOI: 10.1161/circulationaha.114.013258

Cells exhibiting dysregulated growth may express telomerase reverse transcriptase (TERT), the dual function of which consists of maintaining telomere length, in association with the RNA template molecule TERC, and controlling cell growth. Here, we investigated lung TERT in human and experimental pulmonary hypertension (PH) and its role in controlling pulmonary artery smooth muscle cell (PA-SMC) proliferation. Marked TERT expression or activity was found in lungs from patients with idiopathic PH and from mice with PH induced by hypoxia or serotonin-transporter overexpression (SM22-5HTT(+) mice), chiefly within PA-SMCs. In cultured mouse PA-SMCs, TERT was expressed on growth stimulation by serum. The TERT inhibitor imetelstat and the TERT activator TA65 abrogated and stimulated PA-SMC growth, respectively. PA-SMCs from PH mice showed a heightened proliferative phenotype associated with increased TERT expression, which was suppressed by imetelstat treatment. TERC(-/-) mice at generation 2 and TERT(-/-) mice at generations 2, 3, and 4 developed less severe PH than did wild-type mice exposed to chronic hypoxia, with less distal pulmonary artery muscularization and fewer Ki67-stained proliferating PA-SMCs. Telomere length differed between TERC(-/-) and TERT(-/-) mice, whereas PH severity was similar in the 2 strains and across generations. Chronic imetelstat treatment reduced hypoxia-induced PH in wild-type mice or partially reversed established PH in SM22-5HTT(+) mice while simultaneously decreasing TERT expression. Opposite effects occurred in mice treated with TA65. Telomerase exerts telomere-independent effects on PA-SMC growth in PH and may constitute a treatment target for PH.